Primo Brands Beats Q2 Earnings Estimates, Raises 2026 Sales Outlook

Primo Brands Corporation PRMB reported second-quarter 2026 adjusted earnings of 37 cents per share, up 2.8% compared with a year ago and surpassed the Zacks Consensus Estimate of 32 cents.

Net sales rose 3.8% year over year to $1.80 billion and topped the consensus estimate of $1.76 billion. Management said top-line results exceeded expectations. Robust Retail channel growth led by regional spring water and premium brands, along with an earlier-than-expected return to growth in Direct Delivery, supported growth. This was partly offset by lower sales from the exited U.S. Office Coffee Services business.

Following the earnings release, Primo Brands’ shares jumped more than 8% during the trading session. Shares of this Zacks Rank #2 (Buy) stock have risen 19.3% in the past six months, outperforming the industry’s 2.4% growth.

Image Source: Zacks Investment Research

Primo Brands Posts Mixed Margin Trends

Gross profit increased 1.4% year over year to $548.7 million, but the gross margin contracted 80 basis points to 30.5%. Higher transportation costs and depreciation and amortization weighed on profitability, while revenue growth and lower non-recurring integration costs provided a partial offset.

Selling, general and administrative expenses dipped 8.7% year over year to $345.5 million. Lower marketing costs and reduced amortization tied mainly to definite-lived intangible assets helped operating income climb 59.8% year over year to $180.3 million.

Adjusted EBITDA increased 5% to $385 million, with the margin rising 20 basis points year over year to 21.4%.

PRMB Water Mix Highlights Premium Strength

Regional spring water sales rose 4.1% year over year to $911 million, making it the largest water category. Purified water sales increased 1.9% to $556.1 million, while premium water advanced 30.5% to $114.2 million.

Other water sales fell 9.7% to $31.8 million, and the broader Other category slipped 1.9% to $183.1 million. The category mix shows that regional spring and premium offerings were the primary engines of quarterly revenue growth.

PRMB Generates Stronger Cash Flow

As of June 30, 2026, the company generated net cash from continuing operations of $331.7 million, up from $193.8 million seen a year ago. After $190 million in capital expenditures and $32.7 million of additions to intangible assets, free cash flow reached $109 million, up from $52.7 million registered a year ago. Adjusted free cash flow was $328.7 million as of June 30.

As of June 30, 2026, total debt excluding unamortized debt costs and discounts was $5.3 billion. Unrestricted cash and cash equivalents totaled $366.5 million, resulting in net debt of $4.9 billion.

During the quarter, PRMB paid $43.5 million in cash dividends and spent $15.5 million on share repurchases, including brokerage commissions.

PRMB Raises 2026 Sales Growth Outlook

Primo Brands raised its 2026 net sales growth forecast to 2-4% from the prior range of 1-3%. The company reaffirmed adjusted EBITDA guidance of $1.465-$1.515 billion.

Management also maintained base capital expenditures at 4% of net sales and adjusted free cash flow guidance of $790-$810 million.

Other Stocks to Consider in the Consumer Staples Space

Darling Ingredients Inc. DAR, which is a global developer and producer of sustainable natural ingredients, currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here. 

The Zacks Consensus Estimate for Darling Ingredients' current financial-year sales indicates growth of 12.4% from the prior-year level. DAR delivered a trailing four-quarter earnings surprise of 38.9%, on average.

United Natural Foods UNFI, which is the leading distributor of natural, organic and specialty food and non-food products, currently carries a Zacks Rank of 2. 

The Zacks Consensus Estimate for United Natural Foods’ current financial-year sales indicates a drop of 2.1% from the prior-year level. UNFI delivered a trailing four-quarter earnings surprise of 29.9%, on average.

Medifast, Inc. MED, which is a leading manufacturer and distributor of clinically-proven healthy living products and programs, currently carries a Zacks Rank of 2. MED missed the average earnings surprise by a sharp margin in the trailing four quarters. 

The Zacks Consensus Estimate for Medifast’s current financial-year sales indicates a decline of 25.9% from the year-ago number.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research